<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Incidence rates of &lt;EM&gt;Staphylococcus aureus&lt;/EM&gt; bloodstream infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Incidence rates of <em>Staphylococcus aureus</em> bloodstream infection</h1>
<div class="graphic"><div class="figure"><div class="ttl">Incidence rates of <em>Staphylococcus aureus</em> bloodstream infection</div><div class="cntnt"><table cellspacing="0"><colgroup width="10%"></colgroup><colgroup width="20%"></colgroup><colgroup span="3" width="10%"></colgroup><colgroup width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">First author</td> <td class="subtitle1">Population, year</td> <td class="subtitle1">MRSA incidence per 100,000</td> <td class="subtitle1">MSSA incidence per 100,000</td> <td class="subtitle1">Total incidence per 100,000</td> <td class="subtitle1">Comments</td> </tr> <tr class="divider_bottom"> <td>El Atrouni<sup>[1]</sup></td> <td>United States (adults), 1998 to 2005</td> <td class="centered">12.4</td> <td class="centered">25.4</td> <td class="centered">38.2</td> <td>Overall SAB incidence stable during the study period, but the proportion due to MRSA increased.</td> </tr> <tr class="divider_bottom"> <td>Klevens<sup>[2]</sup></td> <td>United States, 2005</td> <td class="centered">23.9</td> <td class="centered">N/A</td> <td class="centered">N/A</td> <td>Most invasive MRSA infections were health care associated.</td> </tr> <tr class="divider_bottom"> <td>Kallen<sup>[3]</sup></td> <td>United States (health care-associated infections only), 2005 to 2008</td> <td class="centered">25.7</td> <td class="centered">N/A</td> <td class="centered">N/A</td> <td>Hospital-onset and health care-associated MRSA bacteremia decreased 34 and 20 percent, respectively, over the four-year period.</td> </tr> <tr class="divider_bottom"> <td>Rhee<sup>[4]</sup></td> <td>United States, 2007 to 2013</td> <td class="centered">16.1</td> <td class="centered">29.6</td> <td class="centered">45.7</td> <td>Community-onset MRSA bacteremia incidence stable during the study period and largely due to USA300 strain type.</td> </tr> <tr class="divider_bottom"> <td>Allard<sup>[5]</sup></td> <td>Canada (adults), 1991 to 2005</td> <td class="centered">3.3</td> <td class="centered">24.3</td> <td class="centered">27.6</td> <td>MRSA incidence increased from 0 to 7.4 per 100,000, while MSSA incidence remained stable.</td> </tr> <tr class="divider_bottom"> <td>Mejer<sup>[6]</sup></td> <td>Denmark (adults), 1995 to 2008</td> <td class="centered">0.18</td> <td class="centered">22.5</td> <td class="centered">22.7</td> <td>Overall SAB incidence stable, and 30-day mortality rate improved during the study period.</td> </tr> <tr class="divider_bottom"> <td>Asgeirsson<sup>[7]</sup></td> <td>Iceland (adults), 1995 to 2008</td> <td class="centered">0.15</td> <td class="centered">24.4</td> <td class="centered">24.5</td> <td>SAB incidence increased during the study period, but mortality improved.</td> </tr> <tr class="divider_bottom"> <td>Huggan<sup>[8]</sup></td> <td>New Zealand, 1998 to 2005</td> <td class="centered">0.08</td> <td class="centered">21.4</td> <td class="centered">21.5</td> <td>Rates stable over time.</td> </tr> <tr class="divider_bottom"> <td>Laupland<sup>[9]</sup></td> <td>Multinational (Australia, Canada, Denmark, Finland, Sweden), 2000 to 2008</td> <td class="centered">1.9</td> <td class="centered">24.2</td> <td class="centered">26.1</td> <td>Community-onset MSSA incidence was similar among study regions. Rates of MRSA and hospital MSSA varied considerably by region. No overall change in burden of SAB over time.</td> </tr> <tr class="divider_bottom"> <td>Jacobsson<sup>[10]</sup></td> <td>Sweden, 2003 to 2005</td> <td class="centered">0</td> <td class="centered">27.6</td> <td class="centered">27.6</td> <td>All cases were MSSA.</td> </tr> <tr class="divider_bottom"> <td>Skogberg<sup>[11]</sup></td> <td>Finland, 2004 to 2007</td> <td class="centered">N/A</td> <td class="centered">N/A</td> <td class="centered">20</td> <td>SAB associated with higher case-fatality rate than other pathogens.</td> </tr> <tr class="divider_bottom"> <td>Tong<sup>[12]</sup></td> <td>Australia, 2006 to 2007</td> <td class="centered">16</td> <td class="centered">49</td> <td class="centered">65</td> <td>SAB incidence rate in the indigenous Australian population was 172 per 100,000.</td> </tr> <tr class="divider_bottom"> <td>Tong<sup>[13]</sup></td> <td>Australia, 2007 to 2010</td> <td class="centered">N/A</td> <td class="centered">N/A</td> <td class="centered">11.2</td> <td>SAB rates higher in indigenous Australians, especially for community-associated MRSA.</td> </tr> <tr class="divider_bottom"> <td>Taylor<sup>[14]</sup></td> <td>Canada, 2011 to 2013</td> <td class="centered">3.95</td> <td class="centered">N/A</td> <td class="centered">N/A</td> <td>66.9 percent of cases were community acquired and 33.1 percent hospital acquired.</td> </tr> <tr> <td class="divider_bottom" rowspan="2">van Cleef<sup>[15]</sup></td> <td>Netherlands, 2009</td> <td class="centered">0.18</td> <td class="centered">19.1</td> <td class="centered">19.3</td> <td class="divider_bottom" rowspan="2">Cross-border comparison between Netherlands and North Rhine-Westphalia, Germany, showing 32-fold higher MRSA bacteremia incidence in Germany.</td> </tr> <tr class="divider_bottom"> <td>Germany, 2009</td> <td class="centered">5.76</td> <td class="centered">N/A</td> <td class="centered">N/A</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Rates in specific subpopulations</td> </tr> <tr class="divider_bottom"> <td class="indent1">Landrum<sup>[16]</sup></td> <td>United States (military), 2005 to 2010</td> <td class="centered">2.0</td> <td class="centered">2.7</td> <td class="centered">4.7</td> <td>Rates of both MRSA and MSSA bacteremia decreased during the study period.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Larsen<sup>[17]</sup></td> <td>Denmark (HIV-infected adults), 1995 to 2007</td> <td class="centered">4.9</td> <td class="centered">489</td> <td class="centered">494</td> <td>50 percent of initial episodes of SAB were in IDUs.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Burkey<sup>[18]</sup></td> <td>United States (HIV-infected adults), 2000 to 2004</td> <td class="centered">850</td> <td class="centered">1110</td> <td class="centered">1960</td> <td>74.7 percent of MRSA bacteremia episodes in IDUs.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Fitzgerald<sup>[19]</sup></td> <td>Ireland (hemodialysis recipients), 1998 to 2009</td> <td class="centered">5600</td> <td class="centered">11400</td> <td class="centered">17000</td> <td>Intravascular catheters implicated as the source in 83 percent of cases.</td> </tr> <tr> <td class="indent1">Wang<sup>[20]</sup></td> <td>Taiwan (all dialysis recipients), 2003 to 2008</td> <td class="centered">1131</td> <td class="centered">678</td> <td class="centered">1809</td> <td>SAB more common among hemodialysis recipients than peritoneal dialysis.</td> </tr> <tr> <td class="indent1">Jaganath<sup>[21]</sup></td> <td>Rural Thailand, 2006 to 2014</td> <td class="centered">0.55</td> <td class="centered">6.8</td> <td class="centered">7.3</td> <td>Community-onset SAB incidence increased during the study period</td> </tr> <tr> <td class="indent1">Jokinen<sup>[22]</sup></td> <td>Filand, 2005 to 2015</td> <td class="centered">0.6 to 4.5</td> <td class="centered">19.9 to 35.2</td> <td class="centered">21.6 to 37.2</td> <td>MSSA and PSSA bacteremia incidence increased, whereas MRSA incidence peaked in 2011</td> </tr> </tbody></table></div><div class="graphic_footnotes">MRSA: methicillin-resistant <em>S. aureus</em>; MSSA: methicillin-susceptible <em>S. aureus</em>; SAB: <em>S. aureus</em> bacteremia; N/A: not applicable; IDU: injection drug user; PSSA: penicillin-susceptible <em>S. aureus</em>.</div><div class="graphic_reference">References: 

<ol>
<li>El Atrouni WI, Knoll BM, Lahr BD, et al. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population based study. Clin Infect Dis 2009; 49:e130.</li>
<li>Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763.</li>
<li>Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010; 304:641.</li>
<li>Rhee Y, Aroutcheva A, Hota B, et al. Evolving epidemiology of Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2015; 36:1417.</li>
<li>Allard C, Carignan A, Bergevin M, et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect 2008; 14:421.</li>
<li>Mejer N, Westh H, Schønheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis 2012; 12:260.</li>
<li>Asgeirsson H, Gudlaugsson O, Kristinsson KG, et al. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality. Clin Microbiol Infect 2011; 17:513.</li>
<li>Huggan PJ, Wells JE, Browne M, et al. Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J 2010; 40:117.</li>
<li>Laupland KB, Lyytikainen O, Sogaard M, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013; 19:465.</li>
<li>Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007; 39:6.</li>
<li>Skogberg K, Lyytikainen O, Ollgren J, et al. Population based burden of bloodstream infections in Finland. Clin Microbiol Infect 2012; 18: E170.</li>
<li>Tong SY, Bishop EJ, Lilliebridge RA, et al. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous northern Australia: epidemiology and outcomes. J Infect Dis 2009; 199:1461.</li>
<li>Tong SY, van Hal SJ, Einsiedel L, et al. Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in indigenous Australians. BMC Infect Dis 2012; 12:249.</li>
<li>Taylor G, Bush K, Leal J, et al. Epidemiology of meticillin-resistant Staphylococcus aureus bloodstream infections in Alberta, Canada. J Hosp Infect 2015; 89:132.</li>
<li>van Cleef BA, Kluytmans JA, van Benthem BH, et al. Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PLoS One 2012; 7:e42787.</li>
<li>Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012; 308:50.</li>
<li>Larsen MV, Harboe ZB, Ladelund S, et al. Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study. HIV Med 2012; 13:45.</li>
<li>Burkey MD, Wilson LE, Moore RD, et al. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med 2008; 9:858.</li>
<li>Fitzgerald SF, O’Gorman J, Morris-Downes MM, et al. A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect 2011; 79:218.</li>
<li>Wang IK, Chang YC, Liang CC, et al. Bacteremia in hemodialysis and peritoneal dialysis patients. Intern Med 2012; 51:1015.</li>
<li>Jaganath D, Possawat J, Sirirat M, et al. Staphylococcus aureus Bacteremia Incidence and Methicillin Resistance in Rural Thailand, 2006-2014. Am J Trop Meg Hyg 2018; 99:155.</li>
<li>Jokinen E, Laine J, Huttunen R, et al. Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia. Infect Dis (Lond) 2018; 50:52.</li></ol></div><div id="graphicVersion">Graphic 94247 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
